PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors
Clinical trial NCT00459836 · COMPLETED
Trial details
- NCT number
- NCT00459836
- Sponsor
- Proacta, Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2009-10-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.